This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
R&D Systems
product type :
ELISA/assay
product name :
DePsipher Mitochondrial Potential Kit
catalog :
6300-100-K
quantity :
100 Tests
price :
339 USD
citations: 13
Reference
Al Nahdi A, John A, Raza H. Cytoprotective Effects of N-Acetylcysteine on Streptozotocin- Induced Oxidative Stress and Apoptosis in RIN-5F Pancreatic β-Cells. Cell Physiol Biochem. 2018;51:201-216 pubmed publisher
Pantovic A, Bosnjak M, Arsikin K, Kosic M, Mandic M, Ristic B, et al. In vitro antiglioma action of indomethacin is mediated via AMP-activated protein kinase/mTOR complex 1 signalling pathway. Int J Biochem Cell Biol. 2017;83:84-96 pubmed publisher
Raza H, John A, Shafarin J. Potentiation of LPS-Induced Apoptotic Cell Death in Human Hepatoma HepG2 Cells by Aspirin via ROS and Mitochondrial Dysfunction: Protection by N-Acetyl Cysteine. PLoS ONE. 2016;11:e0159750 pubmed publisher
Raza H, John A, Shafarin J. NAC attenuates LPS-induced toxicity in aspirin-sensitized mouse macrophages via suppression of oxidative stress and mitochondrial dysfunction. PLoS ONE. 2014;9:e103379 pubmed publisher
Ristic B, Bosnjak M, Arsikin K, Mircic A, Suzin Zivkovic V, Bogdanovic A, et al. Idarubicin induces mTOR-dependent cytotoxic autophagy in leukemic cells. Exp Cell Res. 2014;326:90-102 pubmed publisher
Leisegang K, Bouic P, Menkveld R, Henkel R. Obesity is associated with increased seminal insulin and leptin alongside reduced fertility parameters in a controlled male cohort. Reprod Biol Endocrinol. 2014;12:34 pubmed publisher
Bosnjak M, Ristic B, Arsikin K, Mircic A, Suzin Zivkovic V, Perovic V, et al. Inhibition of mTOR-dependent autophagy sensitizes leukemic cells to cytarabine-induced apoptotic death. PLoS ONE. 2014;9:e94374 pubmed publisher
Strohecker A, Guo J, Karsli Uzunbas G, Price S, Chen G, Mathew R, et al. Autophagy sustains mitochondrial glutamine metabolism and growth of BrafV600E-driven lung tumors. Cancer Discov. 2013;3:1272-85 pubmed publisher
Haines C, Harvey P, Luczak E, Barthel K, Konhilas J, Watson P, et al. Estrogenic compounds are not always cardioprotective and can be lethal in males with genetic heart disease. Endocrinology. 2012;153:4470-9 pubmed publisher
Raza H, John A. Implications of altered glutathione metabolism in aspirin-induced oxidative stress and mitochondrial dysfunction in HepG2 cells. PLoS ONE. 2012;7:e36325 pubmed publisher
Szliszka E, Helewski K, Mizgala E, Krol W. The dietary flavonol fisetin enhances the apoptosis-inducing potential of TRAIL in prostate cancer cells. Int J Oncol. 2011;39:771-9 pubmed publisher
Zogovic N, Nikolic N, Vranjes Djuric S, Harhaji L, Vucicevic L, Janjetovic K, et al. Opposite effects of nanocrystalline fullerene (C(60)) on tumour cell growth in vitro and in vivo and a possible role of immunosupression in the cancer-promoting activity of C(60). Biomaterials. 2009;30:6940-6 pubmed publisher
Budnik L, Mukhopadhyay A. Lysophosphatidic acid-induced nuclear localization of protein kinase C delta in bovine theca cells stimulated with luteinizing hormone. Biol Reprod. 2002;67:935-44 pubmed
product information
brand :
R&D Systems
master code :
6300-100-K
SKU :
6300-100-K
product name :
DePsipher Mitochondrial Potential Kit
target :
Mitochondrial Membrane Potential Disruption Assay
category :
Activity Assays
unit size :
100 Tests
catalog number base :
6300-100-K
USD :
339 USD
storage :
The product requires storage at -20 to -70 °C and 2 - 8 °C. Consult the product insert for specific storage temperatures. Do not use past expiration date.
company information
R&D Systems
614 McKinley Place N.E.
Minneapolis, MN 55413
info@RnDSystems.com
https://www.rndsystems.com
800 343-7475
headquarters: USA
R&D Systems develops and manufactures high-quality proteins and serves as a world leader in immunoassays. R&D Systems also produces quality antibodies, antibody arrays, stem cell and cell culture products, and cell selection and detection products, serving the life science and diagnostics industry.